Vanguard Group’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,859,306
| Closed | -$1.62M | – | 4172 |
|
|
2019
Q2 | $1.62M | Buy |
1,859,306
+907,318
| +95% | +$789K | ﹤0.01% | 3532 |
|
|
2019
Q1 | $2.21M | Buy |
951,988
+713,965
| +300% | +$1.66M | ﹤0.01% | 3416 |
|
|
2018
Q4 | $552K | Sell |
238,023
-429,796
| -64% | -$997K | ﹤0.01% | 3717 |
|
|
2018
Q3 | $9.9M | Buy |
667,819
+67,240
| +11% | +$996K | ﹤0.01% | 2926 |
|
|
2018
Q2 | $9.12M | Buy |
600,579
+220,870
| +58% | +$3.35M | ﹤0.01% | 2948 |
|
|
2018
Q1 | $7.13M | Buy |
379,709
+180,719
| +91% | +$3.39M | ﹤0.01% | 2990 |
|
|
2017
Q4 | $3.61M | Buy |
198,990
+69,875
| +54% | +$1.27M | ﹤0.01% | 3251 |
|
|
2017
Q3 | $2.87M | Buy |
+129,115
| New | +$2.87M | ﹤0.01% | 3299 |
|